Latest / StartUp Health NOW Podcast
Early Detection, Better Outcomes: Transforming Alzheimer’s Diagnosis with CxPM
Imagine this: 73 million Americans are over 65. Among them, 10-20% experience mild cognitive impairment (MCI), a potential precursor to Alzheimer’s. Yet their primary care doctors, with only 14 minutes per patient, lack the time for crucial neurological screenings. This is a critical gap in our healthcare system, especially as groundbreaking Alzheimer’s research and therapies emerge, making early detection more vital than ever.
That’s where Cx Precision Medicine comes in.
In this episode, we sit down with Sid O’Bryant, PhD, and Danguole Altman, the team behind CxPM, a company in the StartUp…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.